Cargando…
Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review
BACKGROUND: The mainstays of cutaneous leishmaniasis (CL) treatment, in several world regions, are pentavalent antimony (Sb(v)) compounds administered parenterally, despite their recognized toxicity, which requires frequent laboratory monitoring and complicates their use in areas with scarce infrast...
Autores principales: | Brito, Nayara Castelano, Rabello, Ana, Cota, Gláucia Fernandes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604971/ https://www.ncbi.nlm.nih.gov/pubmed/28926630 http://dx.doi.org/10.1371/journal.pone.0184777 |
Ejemplares similares
-
Intralesional infiltration versus parenteral use of meglumine antimoniate for treatment of cutaneous leishmaniasis: A cost-effectiveness analysis
por: Brito, Nayara C., et al.
Publicado: (2019) -
Towards a standard protocol for antimony intralesional infiltration
technique for cutaneous leishmaniasis treatment
por: da Silva, Rosiana Estéfane, et al.
Publicado: (2018) -
New World Cutaneous Leishmaniasis Treated with Intralesional Injection of Pentavalent Antimony
por: Shin, Ji Yeon, et al.
Publicado: (2013) -
Intralesional meglumine antimoniate for the treatment of localised
cutaneous leishmaniasis: a retrospective review of a Brazilian referral
centre
por: da Silva, Rosiana Estéfane, et al.
Publicado: (2016) -
Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial
por: Ramalho, Dario Brock, et al.
Publicado: (2018)